Underreported Risk of Lisinopril-Induced Angioedema in a Veteran Population
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280211032404
Abstract: Background: Lisinopril-induced angioedema (LIA) is a rare but serious adverse drug event (ADE) with a published incidence of 0.1% to 0.7%. It is well known that ADEs are widely underreported; however, LIA is one of… read more here.
Keywords: risk; lisinopril induced; induced angioedema; risk lia ... See more keywords
A favipiravir-induced angioedema and urticaria in a COVID-19 patient
Sign Up to like & getrecommendations! Published in 2022 at "Antiviral Therapy"
DOI: 10.1177/13596535221146226
Abstract: Although favipiravir is a promising drug for coronavirus disease 2019, some adverse effects, including skin lesions, have been reported. A 56-year-old female who was prescribed favipiravir by a filiation team following a positive severe acute… read more here.
Keywords: angioedema urticaria; induced angioedema; urticaria covid; favipiravir induced ... See more keywords
Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0224858
Abstract: Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II which causes vasoconstriction. ACE inhibitors reduce blood pressure by inhibiting ACE. A well-known adverse drug reaction to ACE inhibitors is ACE inhibitor-induced angioedema (ACEi-AE). Angioedema is… read more here.
Keywords: induced angioedema; inhibitor induced; systematic review; converting enzyme ... See more keywords